These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31552567)

  • 1. HHLA2 overexpression is a novel biomarker of malignant status and poor prognosis in gastric cancer.
    Wei L; Tang L; Chang H; Huo S; Li Y
    Hum Cell; 2020 Jan; 33(1):116-122. PubMed ID: 31552567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of human endogenous retrovirus-H long terminal repeat-associating protein 2 (HHLA2) expression with gastric cancer prognosis.
    Shimonosono M; Arigami T; Yanagita S; Matsushita D; Uchikado Y; Kijima Y; Kurahara H; Kita Y; Mori S; Sasaki K; Omoto I; Maemura K; Uenosono Y; Ishigami S; Natsugoe S
    Oncotarget; 2018 Apr; 9(31):22069-22078. PubMed ID: 29774123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Checkpoint Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 is Upregulated and Independently Predicts Unfavorable Prognosis in Bladder Urothelial Carcinoma.
    Lin G; Ye H; Wang J; Chen S; Chen X; Zhang C
    Nephron; 2019; 141(4):256-264. PubMed ID: 30602154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target.
    Chen D; Chen W; Xu Y; Zhu M; Xiao Y; Shen Y; Zhu S; Cao C; Xu X
    J Med Genet; 2019 Jan; 56(1):43-49. PubMed ID: 29967134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of HHLA2 predicts poor prognosis in medullary thyroid carcinoma.
    Niu Y; Wang W; Jiang X; Huang Y; Yan S; Jiang Y
    Jpn J Clin Oncol; 2022 Jul; 52(7):759-765. PubMed ID: 35348687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of HHLA2 expression in solid tumors: A meta-analysis based on the Chinese population.
    Zhang C; Xu J; Ye J; Zhang X
    Medicine (Baltimore); 2021 Jul; 100(30):e26789. PubMed ID: 34397730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein.
    Janakiram M; Chinai JM; Fineberg S; Fiser A; Montagna C; Medavarapu R; Castano E; Jeon H; Ohaegbulam KC; Zhao R; Zhao A; Almo SC; Sparano JA; Zang X
    Clin Cancer Res; 2015 May; 21(10):2359-66. PubMed ID: 25549724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance of HHLA2 as a Novel Therapeutic Target for Colorectal Cancer.
    Wang H; An Z; Liu Y; Ding G; Deng G; Ji C; Gong Y
    Curr Cancer Drug Targets; 2024; 24(11):1177-1186. PubMed ID: 38299402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Expression Patterns and Associated Clinical Parameters of Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 and Transmembrane and Immunoglobulin Domain Containing 2 in Oral Squamous Cell Carcinoma.
    Xiao Y; Li H; Yang LL; Mao L; Wu CC; Zhang WF; Sun ZJ
    Dis Markers; 2019; 2019():5421985. PubMed ID: 31089395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic values of B7-H3, B7-H4, and HHLA2 expression in human pancreatic cancer tissues based on mIHC and spatial distribution analysis.
    Zhu Y; Chen J; Liu Y; Zheng X; Feng J; Chen X; Jiang T; Li Y; Chen L
    Pathol Res Pract; 2022 Jun; 234():153911. PubMed ID: 35489125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Endogenous Retrovirus-H Long Terminal Repeat- Associating Protein 2 (HHLA2) is a Novel Immune Checkpoint Protein in Lung Cancer which Predicts Survival.
    Farrag MS; Ibrahim EM; El-Hadidy TA; Akl MF; Elsergany AR; Abdelwahab HW
    Asian Pac J Cancer Prev; 2021 Jun; 22(6):1883-1889. PubMed ID: 34181347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of HHLA2 and CD8 Immunohistochemical Expression in Colorectal Carcinoma and Their Prognostic Significance.
    Gawesh ZM; Ibrahim EM; ElKalla HMHR; Awad AAH; Mohamed MA
    Asian Pac J Cancer Prev; 2023 Dec; 24(12):4309-4319. PubMed ID: 38156868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Potential Immune Checkpoint Member HHLA2 in Human Tumors: A Comprehensive Analysis.
    Wang B; Ran Z; Liu M; Ou Y
    Front Immunol; 2019; 10():1573. PubMed ID: 31379814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma.
    Qi Y; Deng G; Xu P; Zhang H; Yuan F; Geng R; Jiang H; Liu B; Chen Q
    Oncol Rep; 2019 Dec; 42(6):2309-2322. PubMed ID: 31578594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Value of Human Endogenous Retrovirus-H Long Terminal Repeat Associating 2 (HHLA2) in Small Cell Lung Cancer.
    Zhang X; Qin Y; Chen X; Xiong M; Shu S
    Technol Cancer Res Treat; 2024; 23():15330338241240683. PubMed ID: 38613340
    [No Abstract]   [Full Text] [Related]  

  • 17. Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 Possesses Prognostic Significance and Promotes Progression of Papillary Thyroid Cancer.
    Niu Y; Huang Y; Dong A; Sun Y
    Int J Gen Med; 2022; 15():1509-1516. PubMed ID: 35210824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1.
    Jing CY; Fu YP; Yi Y; Zhang MX; Zheng SS; Huang JL; Gan W; Xu X; Lin JJ; Zhang J; Qiu SJ; Zhang BH
    J Immunother Cancer; 2019 Mar; 7(1):77. PubMed ID: 30885276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma.
    Huang FX; Wu JW; Cheng XQ; Wang JH; Wen XZ; Li JJ; Zhang Q; Jiang H; Ding QY; Zhu XF; Zhang XS; Ding Y; Li DD
    Front Immunol; 2022; 13():902167. PubMed ID: 36003385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of HHLA2, a member of the B7 family, is associated with worse survival in human colorectal carcinoma.
    Zhu Z; Dong W
    Onco Targets Ther; 2018; 11():1563-1570. PubMed ID: 29593422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.